about
Innovative technologies in thoracic radiation therapy for lung cancerLimited Stage Follicular Lymphoma: Current Role of Radiation TherapyThe Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.Radiation therapy for older patients with brain tumorsHypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational studyStereotactic radiotherapy for early stage non-small cell lung cancerDifferent IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerationsTreatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapy.Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.A strategy for young members within national radiation oncology societies: the Italian experience (AIRO Giovani group).Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy.New concepts and insights into the role of radiation therapy in extracranial metastatic disease.Role of modern radiation therapy in early stage Hodgkin's lymphoma: A young radiation oncologists' perspective.Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer?Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.Stereotactic body radiotherapy for early stage lung cancer: History and updated role.What do radiation oncologists require for future advancements in lung SBRT?Radiotherapy and immune checkpoints inhibitors for advanced melanoma.Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.Treatment of metastatic melanoma: a multidisciplinary approach.Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation.Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.Efficacy and safety of stereotactic ablative radiotherapy in patients with previous pneumonectomy.Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial.Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation.Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).125I brachytherapy for localized prostate cancer: a single institution experience.Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment.Radical radiotherapy in high-risk prostate cancer patients with high or ultra-high initial PSA levels: a single institution analysis.
P50
Q26863239-C4A18E26-715B-4DEE-BE6A-4652E6F907C9Q28079742-2CEEC96C-D015-4A68-A7F4-22B3A726F122Q33442985-AD8DB5AE-2479-4E07-AB29-D4D729F213A2Q33778385-AE3A4E5F-B87A-4AE2-B5E1-1D4A4DEE1A7DQ33815025-DDB68C7B-BD77-48A6-ABA2-E96DCF37D815Q34989365-DB8EEA1F-BA5A-46C9-9F58-1DB76508324AQ35824255-19A65804-BF0B-46AC-9FCA-2BE5F6B8FCBAQ36412607-E0ED9FE6-0ABB-40F7-85F0-AC5D7B4A7F37Q36892569-0E38805F-A7E3-45E9-9239-B8CCBED9C551Q37176540-12D16D35-A630-47F5-A6C6-8ED0401DDB79Q37187233-EF75ECB8-58AC-4942-98F7-F12816E1BF94Q37453969-F9BAC537-E61C-41DF-952E-37D98D1EDFC6Q38049331-D41BA6D2-7C67-4A48-BC21-49D74DB918CBQ38153442-80CE6C79-742C-4819-AF71-C3BF6F58678CQ38199495-4018B903-DDB2-4687-8424-F0AC71E89E23Q38233871-709765A9-7034-4036-B2D7-9C998EFC6E79Q38244541-2DA81697-0D79-423D-9A97-4D87231219B1Q38443076-3938B4B1-E759-4A61-B027-6C0F1042F430Q38510871-6B904D0C-F1AE-46B8-B55C-FE9BCAD718FCQ38704840-3E8F2E2D-183D-4434-AD71-B85285504EABQ38787599-76B731BF-DEEA-48B3-ADD0-EC97A9787943Q38877565-3CAB4351-CDD5-49F5-A368-2DABAB405864Q38918333-747A9AA5-4685-4C86-83E6-D1566FD85B38Q39177342-4CF07D3E-ADCE-4410-96EF-6649EBF02743Q39213429-0C6D0163-8A98-496F-9762-ADEFC9F59437Q39924019-6E9A7DAE-926E-4DCA-B215-A48C3D563730Q40775154-6E5391B7-115E-4462-9B84-6EFAFDAA66BDQ40896672-684352A4-DECD-4913-AF95-EDA41CDFE11DQ41034587-343A4466-69FC-41C6-A176-2D5F09C7A5ABQ41229585-1009C049-DD6C-43D4-A144-03F55902FA92Q41595193-99732B1B-D697-4BA2-B75A-EEEFD58C5391Q42731446-C35A95C8-EC00-4544-A99C-FA1AACEE35C6Q42852792-14F1DAAE-CC2F-44EA-B0CA-2065561C31AAQ43455935-E483378A-B437-4337-8F66-2C1369711F58Q43477210-54D84D33-5347-4BFF-8654-5B656DD93B2FQ43891809-FD5F40A4-99D7-46DA-94EE-FD0F193E96D5Q44197593-2E566E73-C7F9-4E6E-8073-1CF10C9371C9Q44245158-2F51A274-74C6-4B6A-AE58-46894B378926Q44384467-270789ED-3A6E-4385-9B85-A8A21A986601Q45741346-0D4E6469-4B78-42A5-A5ED-E2CCC5E02B10
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Riccardo Filippi
@ast
Andrea Riccardo Filippi
@en
Andrea Riccardo Filippi
@es
Andrea Riccardo Filippi
@nl
type
label
Andrea Riccardo Filippi
@ast
Andrea Riccardo Filippi
@en
Andrea Riccardo Filippi
@es
Andrea Riccardo Filippi
@nl
prefLabel
Andrea Riccardo Filippi
@ast
Andrea Riccardo Filippi
@en
Andrea Riccardo Filippi
@es
Andrea Riccardo Filippi
@nl
P106
P1153
7006977734
P214
351144782720979197737
P2798
P31
P496
0000-0001-7159-7869
P5008
P734
P735
P7859
viaf-351144782720979197737